对比增强与扩散加权MRI鉴别转移性黏液性结直肠腺癌与肝单纯囊肿
这项回顾性研究纳入29例患者的47个转移性黏液性结直肠腺癌和19个肝单纯囊肿,评估对比增强与扩散加权MRI的鉴别价值。环状强化(OR 28.43)和囊内强化(OR 180.15)是独立预测因子,两者联合诊断敏感度72.3%、特异度94.7%。转移性黏液性结直肠腺癌的表观扩散系数及病灶-肝表观扩散系数比值低于单纯囊肿,肝胆期信号强度及病灶-肝信号强度比值高于单纯囊肿。
要点
- 环状强化和囊内强化是预测转移性黏液性结直肠腺癌的独立因素。
- 囊内强化诊断敏感度87.2%、特异度89.5%,联合环状强化特异度94.7%。
- 转移性黏液性结直肠腺癌表观扩散系数低于单纯囊肿,肝胆期信号强度高于单纯囊肿。
核心结论
- 对比增强与扩散加权MRI可能有助于鉴别转移性黏液性结直肠腺癌与肝单纯囊肿。
研究设计与样本
- 回顾性研究,纳入29例患者的47个转移性黏液性结直肠腺癌和19个肝单纯囊肿,均行对比增强与扩散加权MRI,两名放射科医生共识评估。
关键影像表现/征象
- 转移性黏液性结直肠腺癌出现环状强化(OR 28.43,p=0.008)和囊内强化(OR 180.15,p=0.001)为独立预测因素。
- 转移性黏液性结直肠腺癌平均表观扩散系数为1.92±0.81×10⁻³ mm²/s,低于单纯囊肿的2.99±0.75×10⁻³ mm²/s(p=0.001)。
- 转移性黏液性结直肠腺癌病灶-肝表观扩散系数比值为1.66±0.75×10⁻³ mm²/s,低于单纯囊肿的2.44±0.56×10⁻³ mm²/s(p=0.004)。
- 转移性黏液性结直肠腺癌平均信号强度为400.3±216.3,高于单纯囊肿的222.4±99.3(p=0.039)。
- 转移性黏液性结直肠腺癌肝胆期病灶-肝信号强度比值为0.58±0.16,高于单纯囊肿的0.30±0.14(p<0.001)。
诊断标准与关键数值
- 环状强化诊断转移性黏液性结直肠腺癌的敏感度83%(39/47)、特异度63.2%(12/19)。
- 囊内强化诊断转移性黏液性结直肠腺癌的敏感度87.2%(41/47)、特异度89.5%(17/19)。
- 环状强化联合囊内强化诊断转移性黏液性结直肠腺癌的敏感度72.3%(34/47)、特异度94.7%(18/19)。
- 环状强化预测转移性黏液性结直肠腺癌的OR为28.43(p=0.008),囊内强化OR为180.15(p=0.001)。
临床应用与阅片要点
- 阅片时可关注病灶是否出现环状强化和囊内强化,两者联合时特异度可达94.7%。
- 测量表观扩散系数及病灶-肝表观扩散系数比值有助于鉴别,转移性黏液性结直肠腺癌数值更低。
- 肝胆期信号强度及病灶-肝信号强度比值在转移性黏液性结直肠腺癌中更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE:: To determine the value of contrast-enhanced and diffusion-weighted (DW) MRI for differentiating metastatic mucinous colorectal adenocarcinomas from simple cysts of the liver.
METHODS:: 29 patients with 47 metastatic mucinous colorectal adenocarcinomas and/or 19 simple cysts of the liver who underwent contrast-enhanced and DW MRI were included in this retrospective study. Two radiologists assessed the MRI findings by consensus. Qualitative and quantitative analyses were conducted. Significant MRI findings on univariate and multivariate analyses were assessed, and their diagnostic performances for predicting metastatic mucinous colorectal adenocarcinomas were analyzed.
RESULTS:: The presence of rim enhancement (odds ratio, 28.43; p = 0.008) and intracystic enhancement (oddsratio, 180.15; p = 0.001) were independently significant factors for predicting metastatic mucinous colorectal adenocarcinomas. The sensitivity and specificity of rim enhancement, intracystic enhancement, and their combination for detecting metastatic mucinous colorectal adenocarcinomas were 83% (39/47) and 63.2% (12/19), 87.2% (41/47) and 89.5% (17/19), and 72.3% (34/47) and 94.7% (18/19), respectively. Compared to simple cysts, metastatic mucinous colorectal adenocarcinomas showed significantly lower mean apparent diffusion coefficient (1.92 ± 0.81 vs 2.99 ± 0.75 × 10-3 mm2 s-1; p = 0.001) and lesion-to-liver apparent diffusion coefficient ratio (1.66 ± 0.75 vs 2.44 ± 0.56 × 10-3 mm2 s-1; p = 0.004) and higher mean signal intensity (400.3 ± 216.3 vs 222.4 ± 99.3; p = 0.039) and lesion-to-liver signal intensity ratio on hepatobiliary-phase images (0.58 ± 0.16 vs 0.30 ± 0.14; p < 0.001).
CONCLUSION:: Contrast-enhanced and DW MRI may be helpful for differentiating metastatic mucinous colorectal adenocarcinomas from simple cysts of the liver.
ADVANCES IN KNOWLEDGE:: On contrast-enhanced and DW MRI, rim and intracystic enhancement can be helpful for differentiating metastatic mucinous colorectal adenocarcinomas from simple cysts of the liver.
引用
- Lee JE, Kim SH, Lee S, et al. Differentiating metastatic mucinous colorectal adenocarcinomas from simple cysts of the liver using contrast-enhanced and diffusion-weighted MRI. Br J Radiol. 2018. PMID: 30040437. doi:10.1259/bjr.20180303
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。